Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-09-12
1998-11-10
Campbell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 9321, 424450, 435 691, 4351723, 4353201, 435325, 536 241, 935 22, 935 34, 935 56, 935 60, 935 62, 935 70, A01N 6300, A61K 4800, A61K 9127, C12N 500
Patent
active
058344411
ABSTRACT:
A composition for genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (AAV) material. Typically, the AAV material is plasmid, and comprises a terminal repeat of the AAV genome. Methods are disclosed for introducing genetic material into cells by use of AAV liposomes. Accordingly, genetic material was introduced and integrated into stem cells, T cells, primary tumor cells, or tumor cell lines.
REFERENCES:
patent: 4394488 (1983-07-01), Szoka, Jr. et al.
patent: 4935372 (1990-06-01), Goh
patent: 5126132 (1992-06-01), Rosenberg
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 5198344 (1993-03-01), Croop et al.
patent: 5250431 (1993-10-01), Rudd et al.
patent: 5252479 (1993-10-01), Srivastava et al.
patent: 5436146 (1995-07-01), Shenk et al.
patent: 5587308 (1996-12-01), Carter et al.
JS Cohen (1992) Trends in Biotechnology 10: 87-91.
B Dropulic et al (1994) Human Gene Therapy 5: 927-939.
PA Pizzo et al (1994) Clinical Infectious Diseases 19: 177-196.
ER Kern (1990) In: Antiviral Agents and Viral Diseases of Man, 3rd edition, GJ Galasso et al, eds, pp. 94-95.
Sacramento Bee (Feb. 26, 1994) p. A22.
Sacramento Bee (Nov. 29, 1991) p. B5.
H Collins (Mar. 6, 1993) Philadelphia Inquirer p. A01.
DJ DeNoon (1995) IAC Newsletter DB Accession No. 02944476.
E Tartour et al (1992) Biomedicine and Pharmacotherapy 46: 473-484.
Wang et al., Proc. Natl. Acad. Sci., 84, 7851-7855 (1987).
Marshall, Science, 269:1050-1055 (1995).
Hodgson, Exp. Opin. Ther. Pat., 5(5):459-468 (1995).
Miller et al., F.A.S.E.B., 9:190-199 (1995).
Culver et al., T.I.G., 10(5):174-178 (1994).
Rosenberg et al., Annals Surg., 218(4):455-464 (1993).
Gutierrez et al., Lancet, 339:715-721 (1992).
Rosenberg, S., Cancer Res., (Suppl.) 51, 5074s-5079s (1991).
Crystal, R., Science, 270, 404-410 (1995).
Mulligan, R., Science, 260, 926-930 (1993).
Coghlan et al., New Scientist, 14-15 (1995).
Brown, D., The Washington Post, A22 (Dec. 8, 1995).
Barinaga, M., Science, 266, 1326 (1994).
NIH "Report and Recommendations . . . " Dec. 7, 1995, 1-40.
Faller, D.V. and Baltimore, D., J. Virol., 49:269-272 (1984).
Felgner, P.L. et al., Proc. Natl. Acad. Sci. USA, 84:7413-7417 (1987).
Rose, J.K. et al., Biotechniques, 10:520-525 (1991).
Malone, R. et al., Proc. Natl. Acad. Sci. USA, 86:6077-6081 (1989).
Innes, C.L. et al., J. Virol., 64:957-961 (1990).
Philip, R. et al., J. Biol. Chem., 268:16087-16090 (1993).
Shaefer-Ridder, M. et al., Science, 215:166-168 (1982).
Stribling, R. et al., Proc. Natl. Acad. Sci. USA, 89:11277-11281 (1992).
Zhu, N. et al., Science, 261:209-211 (1993).
Stewart, M.J. et al., Human Gene Therapy, 3:267-275 (1992).
Felgner et al., Nature, 337:387-388 (1989).
Lebkowski, J.S. et al., Mol. Cell. Biol., 8:3988-3996 (1988).
Kotin, R.M. et al., Proc. Natl. Acad. Sci., 87:2211-2215 (1990).
Hermonat, P.L. et al., J. Virol., 51:329-339 (1984).
Graham, F.L. et al., J. Gen. Virol., 36:59-72 (1977).
Hermonat, P.L. and Muzyczka, N., Proc. Natl. Acad. Sci. USA, 81:6466-6470 (1984).
Tratschin, J.D. et al., Mol. Cell. Biol., 5:3251-3260 (1985).
Philip, R. et al., Mol. Cell. Biol., 14(4):2411-2418 (1994).
Oken, Am. J. Clin. Oncol. (CCT), 5:649-655 (1982).
West, W.H. et al., N. Engl. J. Med., 316:898 (1987).
Topolian, S.L. et al., J. Immunol. Methods, 102:127-141 (1987).
Hug et al., Biochem. Biophys. Acta., 1097:1-17 (1991).
Marshall, Science, 269, 1995, 1050-1055.
Hodgson, Exp. Opin. Ther. Pat., 5(5), 1995, 459-468.
Miller et al, FASEB, 9, 1995, 190-199.
Culver et al, TIG, 10(5), 1994, 174-178.
Rosenberg et al, Annals Surg., 218(4), 1993, 455-464.
Gutierrez et, al, The Lancet, 339, 1992, 715-721.
Lebkowski Jane
Philip Ramila
Campbell Bruce R.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
LandOfFree
Adeno-associated viral (AAV) liposomes and methods related there does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adeno-associated viral (AAV) liposomes and methods related there, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated viral (AAV) liposomes and methods related there will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516787